DCEG staff members often receive scientific and professional society awards and recognition. In addition, they present their research at scientific conferences and participate in other events. Read about current DCEG people in the news below, and view an archive of past people in the news.
In January, Gladys M. Glenn, M.D., Ph.D., retired from NCI after 30 years of government service. Over the course of her career, Dr. Glenn combined her background in molecular biology with expertise in clinical genetics to investigate the causes of hereditary kidney cancer and related syndromes. Her accomplishments included identification, with her colleagues, of the von Hippel-Lindau (VHL) disease gene. Dr. Glenn earned an M.D. and a Ph.D. in molecular biology at the University of Pennsylvania Schools of Medicine and Graduate School, respectively, and became board certified in internal medicine. After completing an oncology fellowship at the Johns Hopkins Oncology Center in Baltimore, Maryland. she joined NCI in 1984. Read more about Gladys Glenn.
In January, DCEG scientists participated in the annual NCI Intramural Scientific Investigators Retreat. Three DCEG tenure-track investigators were invited to give presentations highlighting their research. Douglas Lowy, M.D., NCI Deputy Director, presented the 2014 NCI Director’s Innovation Awards, which are designed to support the development of novel approaches and technologies for accelerating cancer research. These include Principal Investigator Awards, and Career Development Awards. In addition, the 2014 NCI Women Scientist Advisors Mentoring and Leadership Award was given. Read the details on the 2014 Intramural Retreat.
Sharon A. Savage, M.D. was named the new Chief of the Clinical Genetics Branch (CGB). She takes over from Mark H. Greene, M.D., who directed the branch since its creation in 1999. Dr. Greene will stay on in CGB as a senior investigator.
Dr. Savage joined CGB in 2006 as a tenure-track investigator and was promoted to senior investigator with tenure in 2012. Her research has focused on the genetic and molecular epidemiology of telomere biology, pediatric cancer etiology, and inherited cancer predisposition syndromes, including dyskeratosis congenita and Li-Fraumeni syndrome. Dr. Savage currently leads an international effort focused on the genetic etiology of osteosarcoma, and serves as the NCI Liaison to the American Academy of Pediatrics Council on Environmental Health. She was recently elected to the American Society of Clinical Investigation in honor of her scholarly achievements in biomedical research.
Sam M. Mbulaiteye, M.D. has been awarded scientific tenure by the NIH. Dr. Mbulaiteye has focused his research on unraveling the role of infections, immunity, and genetic factors in the etiology of Burkitt lymphoma (BL) and Kaposi sarcoma. Both of these diseases are endemic in Africa, with substantially increased risk in the setting of HIV/AIDS. Dr. Mbulaiteye received his primary medical degree from Makerere University, Kampala in 1990. He earned an M.Phil. in epidemiology and biostatistics from the University of Cambridge, U.K. in 1994, and received specialization in internal medicine (M. Med.) from Makerere University in 1996. Read more about Dr. Mbulaiteye.
Four DCEG fellows were selected to receive the 2014 Sallie Rosen Kaplan (SRK) Postdoctoral Fellowship for Women Scientists in Cancer Research: Anna Coghill, Ph.D., M.P.H., Immunoepidemiology and Infections Branch; Ashley Felix, Ph.D., Hormonal and Reproductive Epidemiology Branch, Kristin Guertin, Ph.D., M.P.H., Nutrition Epidemiology Branch; and Rena Jones, Ph.D., M.S., Occupational and Environmental Epidemiology Branch. The goal of the SRK program is to better equip NCI female postdoctoral fellows to remain in a biomedical research career. Fellows will receive additional mentoring and will take part in seminars and workshops designed to strengthen leadership skills.